BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance
Authors
Keywords
-
Journal
Science Advances
Volume 4, Issue 7, Pages eaas9944
Publisher
American Association for the Advancement of Science (AAAS)
Online
2018-07-12
DOI
10.1126/sciadv.aas9944
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel splenic B1 regulatory cell subset suppresses allergic disease through phosphatidylinositol 3-kinase–Akt pathway activation
- (2016) Takashi Matsushita et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
- (2016) Dinesh Khanna et al. LANCET
- Marginal zone B cells exacerbate endotoxic shock via interleukin-6 secretion induced by Fcα/μR-coupled TLR4 signalling
- (2016) Shin-ichiro Honda et al. Nature Communications
- Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity
- (2015) Takashi Matsushita et al. RHEUMATOLOGY
- Transcriptomics Identify CD9 as a Marker of Murine IL-10-Competent Regulatory B Cells
- (2015) Jianbo Sun et al. Cell Reports
- Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
- (2014) Suzana Jordan et al. ANNALS OF THE RHEUMATIC DISEASES
- TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity
- (2014) V. Lampropoulou et al. JOURNAL OF IMMUNOLOGY
- Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
- (2014) Ludwig Kappos et al. LANCET NEUROLOGY
- Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease
- (2013) D. Le Huu et al. BLOOD
- B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis
- (2013) Antoine François et al. ARTHRITIS RESEARCH & THERAPY
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
- (2012) Tom A. Barr et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-6 Blockade Attenuates the Development of Murine Sclerodermatous Chronic Graft-Versus-Host Disease
- (2012) Doanh Le Huu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions
- (2012) Ayumi Yoshizaki et al. NATURE
- Depletion of B2 but Not B1a B Cells in BAFF Receptor-Deficient ApoE−/− Mice Attenuates Atherosclerosis by Potently Ameliorating Arterial Inflammation
- (2012) Tin Kyaw et al. PLoS One
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- IL-10 produced by activated human B cells regulates CD4+ T-cell activation in vitro
- (2010) Jean-David Bouaziz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cutting Edge: Novel Function of B Cell-Activating Factor in the Induction of IL-10-Producing Regulatory B Cells
- (2010) M. Yang et al. JOURNAL OF IMMUNOLOGY
- Protective and Pathogenic Roles for B Cells during Systemic Autoimmunity in NZB/W F1 Mice
- (2010) K. M. Haas et al. JOURNAL OF IMMUNOLOGY
- The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
- (2010) Y. Shima et al. RHEUMATOLOGY
- B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial
- (2010) Silvia Bosello et al. ARTHRITIS RESEARCH & THERAPY
- Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
- (2009) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
- (2008) Koichi Yanaba et al. IMMUNITY
- Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
- (2008) Takashi Matsushita et al. JOURNAL OF CLINICAL INVESTIGATION
- Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse
- (2007) K Komura et al. ANNALS OF THE RHEUMATIC DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started